Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Q Del Prete

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Plos Pathogens|May 5, 2017
Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapyChristine M Fennessey, Mykola Pinkevych, Taina T Immonen, et al.
Journal of Virology|July 15, 2016
Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal InfectionMichael J Lopker, Gregory Q Del Prete, Jacob D Estes, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Elevated Plasma Viral Loads in Romidepsin-Treated Simian Immunodeficiency Virus-Infected Rhesus Macaques on Suppressive Combination Antiretroviral TherapyGregory Q Del Prete, Kelli Oswald, Abigail Lara, et al.
Journal of Virology|January 13, 2012
Restricted replication of xenotropic murine leukemia virus-related virus in pigtailed macaquesGregory Q Del Prete, Mary F Kearney, Jon Spindler, et al.
Plos Pathogens|July 13, 2018
Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIVVickie A Marshall, Nazzarena Labo, Xing-Pei Hao, et al.
Cell Host & Microbe|September 12, 2014
Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteinsGregory Q Del Prete, Braiden Eilers, Brian Moldt, et al.
Ebiomedicine|August 25, 2023
Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIVAdrienne E Swanstrom, Robert J Gorelick, Jorden L Welker, et al.
Plos Pathogens|April 4, 2019
Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopesSean P O'Brien, Adrienne E Swanstrom, Amarendra Pegu, et al.
Nature Communications|August 19, 2015
Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infectionXing Pei Hao, Carissa M Lucero, Baris Turkbey, et al.
Antimicrobial Agents and Chemotherapy|September 4, 2014
Effect of suberoylanilide hydroxamic acid (SAHA) administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-infected indian rhesus macaquesGregory Q Del Prete, Rebecca Shoemaker, Kelli Oswald, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Plos Pathogens|May 5, 2017
Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapyChristine M Fennessey, Mykola Pinkevych, Taina T Immonen, et al.
Journal of Virology|July 15, 2016
Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal InfectionMichael J Lopker, Gregory Q Del Prete, Jacob D Estes, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2015
Elevated Plasma Viral Loads in Romidepsin-Treated Simian Immunodeficiency Virus-Infected Rhesus Macaques on Suppressive Combination Antiretroviral TherapyGregory Q Del Prete, Kelli Oswald, Abigail Lara, et al.
Journal of Virology|January 13, 2012
Restricted replication of xenotropic murine leukemia virus-related virus in pigtailed macaquesGregory Q Del Prete, Mary F Kearney, Jon Spindler, et al.
Plos Pathogens|July 13, 2018
Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIVVickie A Marshall, Nazzarena Labo, Xing-Pei Hao, et al.
Cell Host & Microbe|September 12, 2014
Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteinsGregory Q Del Prete, Braiden Eilers, Brian Moldt, et al.
Ebiomedicine|August 25, 2023
Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIVAdrienne E Swanstrom, Robert J Gorelick, Jorden L Welker, et al.
Plos Pathogens|April 4, 2019
Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopesSean P O'Brien, Adrienne E Swanstrom, Amarendra Pegu, et al.
Nature Communications|August 19, 2015
Experimental colitis in SIV-uninfected rhesus macaques recapitulates important features of pathogenic SIV infectionXing Pei Hao, Carissa M Lucero, Baris Turkbey, et al.
Antimicrobial Agents and Chemotherapy|September 4, 2014
Effect of suberoylanilide hydroxamic acid (SAHA) administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-infected indian rhesus macaquesGregory Q Del Prete, Rebecca Shoemaker, Kelli Oswald, et al.
Pageof 6